Bulk Manufacturer of Controlled Substances Application: Austin Pharma LLC, 50043 [2015-20284]
Download as PDF
<![CDATA[
Federal Register / Vol. 80, No. 159 / Tuesday, August 18, 2015 / Notices
denial’ ’’ of his withdrawal request. Id.
at 3 (quoting 5 U.S.C. 555(e)).
Because the Office of Diversion
Control had not complied with section
555(e), the then-Administrator denied
the Government’s Request for Final
Agency Action. Id. The thenAdministrator returned the record to the
Government’s Counsel, with the
instruction that its Request should not
be re-submitted until such time as the
Office of Diversion Control complied
with 5 U.S.C. 555(e) and explained why
Applicant has not demonstrated good
cause to withdraw his application, as
well as why the withdrawal is not in the
public interest. Id.
On August 7, 2015, Government
Counsel filed a Request for Dismissal of
Order to Show Cause. Therein,
Government Counsel represents that on
July 30, 3015, the Office of Diversion
Control had decided to allow
Respondent to withdraw his
application. The Government therefore
requests an Order dismissing the Show
Cause Order.
Because the Office of Diversion
Control has granted Respondent’s
withdrawal request, there is no longer
an application to act upon and the case
is now moot. See Thomas E. Mitchell,
76 FR 20032, 20033 (2011).
Accordingly, I grant the Government’s
Request and dismiss the Order to Show
Cause.
Order
Pursuant to the authority vested in me
by 21 U.S.C. 823(f), as well as 28 CFR
0.100(b), I order that the Order to Show
Cause issued to Matthew Valentine/Liar
Catchers be, and it hereby is, dismissed.
This Order is effective immediately.
Dated: August 10, 2015.
Chuck Rosenberg,
Acting-Administrator.
[FR Doc. 2015–20344 Filed 8–17–15; 8:45 am]
BILLING CODE 4410–09–P
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/ODXL, 8701
Morrissette Drive, Springfield, Virginia
22152. Request for hearings should be
sent to: Drug Enforcement
Administration, Attention: Hearing
Clerk/LJ, 8701 Morrissette Drive,
Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Deputy Assistant
Administrator of the DEA Office of
Diversion Control (‘‘Deputy Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.33(a), this is notice that on April
23, 2015, Austin Pharma LLC, 811
Paloma Drive, Suite C, Round Rock,
Texas 78665–2402 applied to be
registered as a bulk manufacturer of the
following basic classes of controlled
substances:
ADDRESSES:
Controlled substance
Marihuana (7360) .........................
Tetrahydrocannabinols (7370) .....
Schedule
I
I
The company plans to manufacture
bulk synthetic active pharmaceutical
ingredients (APIs) for product
development and distribution to its
customers. No other activity for this
drug code is authorized for this
registration.
Drug Enforcement Administration
Dated: August 10, 2015.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[Docket No. DEA–392]
[FR Doc. 2015–20284 Filed 8–17–15; 8:45 am]
DEPARTMENT OF JUSTICE
BILLING CODE 4410–09–P
asabaliauskas on DSK5VPTVN1PROD with NOTICES
Bulk Manufacturer of Controlled
Substances Application: Austin
Pharma LLC
ACTION:
DEPARTMENT OF JUSTICE
[OMB Number 1121–0335]
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration in
accordance with 21 CFR 1301.33(a) on
or before October 19, 2015.
DATES:
VerDate Sep<11>2014
17:02 Aug 17, 2015
Jkt 235001
Agency Information Collection
Activities; Proposed eCollection
eComments Requested; National
Motor Vehicle Title Information System
(NMVTIS)
Bureau of Justice Assistance,
Department of Justice.
AGENCY:
PO 00000
Frm 00059
Fmt 4703
Sfmt 4703
ACTION:
50043
30-Day notice.
The Department of Justice,
Office of Justice Programs, Bureau of
Justice Assistance, will submit the
following information collection request
for review and clearance in accordance
with the Paperwork Reduction Act of
1995. The proposed information
collection was previously published in
80 FR 32180, on June 5, 2015, allowing
for a 60-day comment period.
SUMMARY:
Comments are encouraged and
will be accepted for an additional 30
days until September 17, 2015.
DATES:
If
you have additional comments,
suggestions, or need a copy of the
proposed information collection
instrument with instructions or
additional information, please contact
C. Casto at 1–202–353–7193, Bureau of
Justice Assistance, Office of Justice
Programs, U. S. Department of Justice,
810 7th Street NW., Washington, DC,
20531 or by email at Chris.Casto@
usdoj.gov. You may also contact the
Office of Management and Budget,
Office of Information and Regulatory
Affairs, Attention Department of Justice
Desk Officer, Washington, DC 20503.
Additionally, comments may be
submitted via email to OIRA_
submissions@omb.eop.gov.
FOR FURTHER INFORMATION CONTACT:
Written
comments and suggestions from the
public and affected agencies concerning
the proposed collection of information
are encouraged. Your comments should
address one or more of the following
four points:
SUPPLEMENTARY INFORMATION:
—Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the National Motor
Vehicle Title Information System
(NMVTIS), including whether the
information will have practical utility;
—Evaluate the accuracy of the agency’s
estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
—Evaluate whether and if so how the
quality, utility, and clarity of the
information to be collected can be
enhanced; and
—Minimize the burden of the collection
of information on those who are to
respond, including through the use of
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms
of information technology, e.g.,
permitting electronic submission of
responses.
E:\FR\FM\18AUN1.SGM
18AUN1
]]>Agencies
[Federal Register Volume 80, Number 159 (Tuesday, August 18, 2015)]
[Notices]
[Page 50043]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-20284]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Bulk Manufacturer of Controlled Substances Application: Austin
Pharma LLC
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration in accordance with 21 CFR
1301.33(a) on or before October 19, 2015.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/ODXL,
8701 Morrissette Drive, Springfield, Virginia 22152. Request for
hearings should be sent to: Drug Enforcement Administration, Attention:
Hearing Clerk/LJ, 8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The Attorney General has delegated his
authority under the Controlled Substances Act to the Administrator of
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority
to exercise all necessary functions with respect to the promulgation
and implementation of 21 CFR part 1301, incident to the registration of
manufacturers, distributors, dispensers, importers, and exporters of
controlled substances (other than final orders in connection with
suspension, denial, or revocation of registration) has been redelegated
to the Deputy Assistant Administrator of the DEA Office of Diversion
Control (``Deputy Assistant Administrator'') pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR 1301.33(a), this is notice that on April
23, 2015, Austin Pharma LLC, 811 Paloma Drive, Suite C, Round Rock,
Texas 78665-2402 applied to be registered as a bulk manufacturer of the
following basic classes of controlled substances:
------------------------------------------------------------------------
Controlled substance Schedule
------------------------------------------------------------------------
Marihuana (7360)........................... I
Tetrahydrocannabinols (7370)............... I
------------------------------------------------------------------------
The company plans to manufacture bulk synthetic active
pharmaceutical ingredients (APIs) for product development and
distribution to its customers. No other activity for this drug code is
authorized for this registration.
Dated: August 10, 2015.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2015-20284 Filed 8-17-15; 8:45 am]
BILLING CODE 4410-09-P
